Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors

doi:10.3748/wjg.v20.i42.15920

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 42

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4593)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

265

WORD

194

HTML

2059

Figures (1-3)

123

Sum=2641

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

901

Download

1042

Sum=1943

Nov 14, 2014 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Nov 14, 2014; 20(42): 15920-15924
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15920

Full Size Figure Download Figure

Figure 1 Abdominal enhanced computed tomography showed a contrast-enhanced tumor lesions accompanied by cystic changes in the liver and the pancreatic tail.

Citation: Kawaguchi Y, Maruno A, Kawashima Y, Ito H, Ogawa M, Mine T. Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors. World J Gastroenterol 2014; 20(42): 15920-15924
URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15920.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15920